Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Sanofi SA    SNY

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Sanofi SA
Engages in the research, production and distribution of pharmaceutical products

Sanofi engages in the research, production and distribution of pharmaceutical products.

It operates through the following segments: Pharmaceuticals, Human Vaccines, and Animal Health.

The Pharmaceuticals segment includes research, development, production and sales activities relating to pharmaceutical products, including prescription, consumer health care, and generic products.

This segment also includes equity affiliates and joint ventures with pharmaceutical business activities.

The Human Vaccines segment includes research, development, production and marketing of vaccines.

The Animal Health segment comprises the research, development, production and marketing activities for Merial, which offers a range of medicines and vaccines for a wide variety of animal species.The company was founded on April 28, 1994 and is headquartered in Paris, France.

Number of employees : 115 631 persons.
Sales per Businesses
20142015Delta
USD (in Million)%USD (in Million)%
Pharmaceuticals36,62882.1%32,88886.3% -10.21%
Vaccines5,25111.8%5,23513.7% -0.31%
Animal Health2,7436.1%---
Sales per Regions
20142015Delta
USD (in Million)%USD (in Million)%
United States14,98333.6%13,51535.5% -9.79%
Western Europe7,12316%5,79215.2% -18.69%
Latin America4,44410%3,3638.8% -24.32%
Asia4,2359.5%3,90310.2% -7.85%
Eastern Europe and Turkey3,3587.5%2,6116.8% -22.23%
France3,2697.3%2,4816.5% -24.1%
Japan2,8006.3%2,2455.9% -19.83%
Other1,5533.5%252.740.7% -83.72%
Rest of the World1,4533.3%1,5084% +3.72%
Middle East1,4053.1%---
Africa and Middle-East--2,4526.4%-
Managers
NameAgeSinceTitle
Olivier Brandicourt MD, PhD602015Chief Executive Officer & Director
Serge Weinberg652009Chairman
Jérôme Contamine592009Chief Financial Officer & EVP-Finance
Elias E. Zerhouni, MD652011President-Global Research & Development
Yong-Jun Liu MD, PhD-2016Head-Global Research & Development
Ameet Nathwani MD, MBA-2016Group Chief Medical Officer & Executive VP
Robert Castaigne, PhD702000Independent Director
Jean-René Fourtou772004Independent Director
Claudie Haigneré MD, PhD592008Independent Director
Uwe Bicker MD, PhD712008Independent Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 1,287,105,713 1,154,406,514 89.7% 100,000 0.0% 89.7%
Shareholders
NameEquities%
Dodge & Cox 59,267,298 2.30%
Barrow, Hanley, Mewhinney & Strauss LLC 31,320,327 1.21%
Franklin Advisers, Inc. 20,829,292 0.81%
Fisher Asset Management LLC 12,443,197 0.48%
Hotchkis & Wiley Capital Management LLC 12,041,028 0.47%
Boston Partners Global Investors, Inc. 8,868,295 0.34%
Invesco Advisers, Inc. 8,342,067 0.32%
Federated Investment Management Co. 5,700,324 0.22%
Fidelity Management & Research Co. 5,542,345 0.22%
Managed Account Advisors LLC 4,566,822 0.18%
Holdings
NameEquities%Valuation
Regeneron Pharmaceuticals Inc (REGN) 23,418,39622.7%8,079,814,988 USD
Aventis Pharma Limited (AVPH) 13,909,58760.4%907,679,975 USD
Alnylam Pharmaceuticals, Inc. (ALNY) 10,256,63312.0%365,136,135 USD
Sanofi (SAN) 3,956,7080.31%307,777,873 USD
Zentiva SA (ROSCD) 312,341,64974.9%151,938,595 USD
Myokardia Inc (MYOK) 3,668,89911.9%49,346,692 USD
Voyager Therapeutics Inc (VYGR) 2,477,9419.26%29,735,292 USD
Regulus Therapeutics Inc (RGLS) 5,053,7799.57%13,897,892 USD
Proteome Sciences plc (PRM) 38,0000.017%2,538 USD
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Pharmaceuticals - NEC
Advertisement
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
SANOFI SA-5.28%104 027
JOHNSON & JOHNSON9.29%305 407
ROCHE HOLDING LTD.-17.58%193 824
PFIZER INC.-4.15%192 367
NOVARTIS AG-18.49%182 959
MERCK & CO., INC.15.92%168 820
SANOFI-2.89%104 027
BRISTOL-MYERS SQUIBB C..-17.08%95 327
GLAXOSMITHKLINE PLC7.65%90 628
BAYER AG-18.36%82 541
ELI LILLY AND CO-20.26%74 903
NOVO NORDISK A/S-36.51%72 596
ALLERGAN PLC-38.48%72 109
ASTRAZENECA PLC-7.29%68 135
ABBOTT LABORATORIES-12.71%57 715
SHIRE PLC-5.65%50 424
TAKEDA PHARMACEUTICAL ..-21.73%32 184
ASTELLAS PHARMA INC-10.80%28 621
MYLAN NV-33.31%19 537
EISAI CO., LTD-13.04%17 695
JIANGSU HENGRUI MEDICI..-80.90%15 950
Sector Pharmaceuticals - NEC
Sanofi SA : Connections
Sanofi
54, rue La Boétie
Paris, Ile-de-France 75008

Phone : +33.1.53.77.40.00
Fax : +33.1.53.77.44.63
Web : www.sanofi.com
© 2016 People , Fundamentals and Ownership